Drug Trial

Future treatments currently under development: A number of organisations are actively developing new, innovative potential treatments for Lupus. As the knowledge base of Lupus deepens, organisations are striving to develop specific treatments that will bring significant benefit over existing treatments. Immupharma plc, London is one organisation with a promising drug candidate in IPP-201101, which is entering a combined Phase II/III trial. It has the potential to be Lupus-specific in the treatment of symptoms and underlying disease progression. For further information, please visit www.immupharma.com